Gilder Gagnon Howe & CO LLC Charles River Laboratories International, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $5.58 Million - $7.9 Million	-21,824 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $377,733 - $482,331	-1,075 Reduced 4.69%	21,824 $8.22 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $1,863 - $2,291	-5 Reduced 0.02%	22,899 $9.45 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $719,833 - $909,427	-2,447 Reduced 9.65%	22,904 $8.47 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $11,984 - $14,375	48 Added 0.19%	25,351 $7.35 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $51,060 - $58,102	230 Added 0.92%	25,303 $6.32 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $27,914 - $36,005	-159 Reduced 0.63%	25,073 $5.68 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $3 Million - $4.79 Million	25,232 New	25,232 $4.4 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.